Lantheus Holdings (LNTH) Non-Current Deferred Tax Liability (2014 - 2026)

Lantheus Holdings' (LNTH) quarterly Non-Current Deferred Tax Liability came in at $53.5 million in Q1 2026, down 1.36% on a QoQ basis from $54.2 million in Q4 2025.

Lantheus Holdings (LNTH) Non-Current Deferred Tax Liability (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 5 years of Non-Current Deferred Tax Liability data on file, last reported at $53.5 million in Q1 2026.

  • On a quarterly basis, Non-Current Deferred Tax Liability changed N/A year-over-year to $53.5 million in Q1 2026; TTM through Mar 2026 was $53.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $54.2 million, changed N/A from the prior year.
  • Non-Current Deferred Tax Liability for Q1 2026 stood at $53.5 million, down from $54.2 million in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for LNTH reached as high as $55.1 million in Q3 2025 and fell as low as $53.5 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Lantheus Holdings 6.72 Bn 6.22 Bn 230.92 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 53.51 Mn
Mar 31, 2026 53.51 Mn
Dec 31, 2025 54.25 Mn
Dec 31, 2025 54.25 Mn
Sep 30, 2025 55.08 Mn
Sep 30, 2025 55.08 Mn
Dec 31, 2016 33.20 Mn
Dec 31, 2016 33.20 Mn
Mar 31, 2016 200,000.00
Mar 31, 2016 200,000.00
Dec 31, 2015 32.90 Mn
Dec 31, 2015 32.90 Mn
Dec 31, 2014 247,000.00
Dec 31, 2014 247,000.00